MIS BAIR: Allergies
Trial phase | Recruitment | Randomisation/birth | Discharge | 7 days post randomisation | 3 months | 6 months | 9 months | 12 months | End Part 1 | 18 months | 24 months | 30 months | 36 months | 42 months | 48 months | 54 months | 60 months | End Part 2 | 5-6 yrs COVID Immune |
6-7 yrs COVID Immune |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Year data collected | 2013-2016 | 2013-2016 | 2013-2016 | 2013-2016 | 2013-2016 | 2014-2017 | 2014-2017 | 2014-2018 | 2015-2018 | 2015-2018 | 2016-2019 | 2016-2019 | 2017-2020 | 2017-2020 | 2018-2021 | 2018-2021 | 2020: Baseline | 2021: 12 mth follow-up |
||
Wheezing | P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
P:ISAAC P:BIS |
||||||||
Asthma | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
P:SDV 3 | P:SDV 3 | P:SDV 3 | P:SDV 3 | P:SDV 3 | P:SDV 3 | P:SDV 3 | P:SDV 3 | |||||||||||
Eczema | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
P:POEM P:SDV 3 |
P:POEM P:SDV 3 |
P:POEM P:SDV 3 |
P:POEM P:SDV 3 O:SCORAD |
P:POEM P:SDV 3 |
P:POEM P:SDV 3 O:SCORAD |
P:POEM P:SDV 3 |
P:POEM P:SDV3 O:SCORAD |
P:POEM P:SDV 3 |
P:POEM P:SDV 3 |
P:POEM P:SDV 3 |
P:POEM P:SDV 3 O:SCORAD |
|||||||
Epipen/Anapen prescription/use | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | |||||||
Family history of allergy | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
|||||||||||||||||||
Food allergies | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | |||||||
Hay fever | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
|||||||||||||||||||
Impact of allergies | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
|||||||||||||||||||
Other allergy | P:HN BM BF Si 1 2 P:BIS BM BF Si 1 2 |
P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | P:HN | |||||||
Skin prick test 4 | O:SPT | O:SPT | ||||||||||||||||||
Oral food challenge 4 | O:OFC | O:OFC |
Featured measurements
BIS: Barwon Infant Study derivedBTS/SIGN: British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) British guideline on the management of asthma
HN: HealthNuts Study derived
ISAAC: International Study of Asthma and Allergy in Children adaptation
OFC: Oral Food Challenge (HealthNuts protocol)
POEM: Patient-Oriented Eczema Measure
SCORAD: SCORing Atopic Dermatitis
SPT: Skin Prick Test (HealthNuts protocol)
Notes
1 Full or half siblings only, not step-siblings
2 Family medical history questions are derived from HealthNuts and the Barwon Infant Study (BIS), and are based in part on ISAAC questions and BTS/SIGN guidelines (October 2014 version)
3 Asthma/eczema questions derived from BIS, ISAAC and BTS/SIGN guidelines
4 SPT and OFC protocols based on BIS and HealthNuts protocols
Legend
A | = Administration report abstraction |
C | = Index child report (reporting on others) |
L | = Linkage (to other databases) |
M | = Medical records data abstraction |
O | = Observation/direct assessment |
N | = Nurse report |
P | = Parent/primary caregiver report |
Pe | = Peer report |
S | = Self report |
T | = Teacher report |
X | = Undefined |
X BF | = Pertaining to biological father |
X BM | = Pertaining to biological mother |
X C | = Pertaining to index child |
X F | = Pertaining to father |
X Fam | = Pertaining to family |
X G | = Pertaining to grandparent(s) |
X M | = Pertaining to mother |
X P | = Pertaining to parent(s) |
X Pa | = Pertaining to partner |
X Pe | = Pertaining to peers |
X Pr | = Pertaining to primary caregiver |
X Si | = Pertaining to sibling(s) |